Visual impairment in adults signals broader health issues and is linked to a higher risk for death, particularly from ...

American adults who lose the eyesight they need to accomplish everyday tasks are almost twice as likely to be depressed as other adults, an analysis of data from a large federal health survey has ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers said changes in the optic disc can predict who will develop blind spots in their vision or lose sharpness of vision ...

Scientists at UC Irvine have found a way to potentially reverse age-related vision loss by targeting the ELOVL2 “aging gene” and restoring vital fatty acids in the retina. Their experiments in mice ...

Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen your figure, but they could also cloud your vision in the process. A review published in JAMA Ophthalmology uncovered at least ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...

LOUISVILLE, Ky. (WKRC) - Patients using popular weight loss medications, such as Ozempic and Wegovy, are being urged to undergo regular eye examinations due to a potential risk of vision loss. Medical ...

A groundbreaking study has unveiled potential concerns regarding semaglutide, the active ingredient in popular weight loss medications like Ozempic and Wegovy. The research suggests a possible ...

Please provide your email address to receive an email when new articles are posted on . Researchers found a “two-phase relationship” between integrated visual fields and Low Luminance Questionnaire ...

Most vision loss is preventable, yet many New Zealanders can’t afford care. Following Australia’s public funding model could ...

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following a recent study that suggests a link between the medications and a sudden, ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced the launch of All Eyes on DME, a campaign ...